InvestorsHub Logo
Followers 34
Posts 2995
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Friday, 01/07/2022 6:53:57 PM

Friday, January 07, 2022 6:53:57 PM

Post# of 460265
Although we have many near term catalysts, I hope Missling gives more attention to our Alz trial during his presentations.

Highlight our platform, emphasize our PDD and our correlation with Alzheimers.

Of course in addition to our Rett results helping to prove our MOA.

Being seen as a credible Alz treatment will make a splash.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News